2010
DOI: 10.1002/ejoc.201000643
|View full text |Cite
|
Sign up to set email alerts
|

3‐Alkenyl‐oxindoles: Natural Products, Pharmaceuticals, and Recent Synthetic Advances in Tandem/Telescoped Approaches

Abstract: The structures and biological activities of naturally occurring 3‐alkenyl‐oxindoles are reviewed. Important man‐made3‐alkenyl‐oxindoles are covered, particularly those with pharmaceutical applications such as sunitinib (SU11248), the orally active receptor tyrosine kinase inhibitor marketed by Pfizer as Sutent®. Traditional synthetic approaches to 3‐alkenyl‐oxindoles are summarised and then recently developed tandem/telescoped synthetic routes are described.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
106
0
3

Year Published

2011
2011
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 331 publications
(109 citation statements)
references
References 105 publications
0
106
0
3
Order By: Relevance
“…[19] We therefore decided to investigate the preparation of heterocyclic CA4 analogues containing a stereochemically defined substituted exocyclic alkene, by using these palladium-catalyzed domino processes. [20] We first planned to synthesize CA4 analogues with a heterocycle fused to the B-ring by using the tandem Heck carbocyclization/Suzuki cross-coupling process (Scheme 1). As we previously reported, under the optimized reaction conditions [Pd(OAc) 2 , PPh 3 , CsF] this tandem reaction occurred with the N-protected propynamide 6 c and the N-free butynamides 6 a and 6 b as starting materials.…”
Section: Chemistrymentioning
confidence: 99%
“…[19] We therefore decided to investigate the preparation of heterocyclic CA4 analogues containing a stereochemically defined substituted exocyclic alkene, by using these palladium-catalyzed domino processes. [20] We first planned to synthesize CA4 analogues with a heterocycle fused to the B-ring by using the tandem Heck carbocyclization/Suzuki cross-coupling process (Scheme 1). As we previously reported, under the optimized reaction conditions [Pd(OAc) 2 , PPh 3 , CsF] this tandem reaction occurred with the N-protected propynamide 6 c and the N-free butynamides 6 a and 6 b as starting materials.…”
Section: Chemistrymentioning
confidence: 99%
“…3b). For example, a novel class of receptor tyrosine kinase inhibitors synthesized from 3-alkenyl oxindole and has been used as anticancer and arthritis drugs 43 . Our laboratories are interested in plant viruses that cause detrimental effects on agriculture and horticulture 44 .…”
Section: Resultsmentioning
confidence: 99%
“…A similar methodology was applied by the same research group for the synthesis of antiprotealide (22, Scheme 2), an omuralide-salinosporamide-type proteasome inhibitor: [19b] the same type of transformation was accomplished by treatment of the acrylamide 20 with the Kulinkovich reagent, generated in situ from Ti(OiPr) 4 and cyclopentylmagnesium bromide, followed by iodinolysis. The obtained α-iodomethyl γ-lactam could easily be converted into the desired α-methylene γ-lactam 21 under basic conditions, and the product 21, formed as single diastereoisomer, was further transformed into antiprotealide (22) in eight steps.…”
Section: Intramolecular Baylis-hillman Reactions In Syntheses Of α-Almentioning
confidence: 99%
“…Recent reviews by Janecki [3a] and by Feray and Bertrand [3b] briefly summarize synthetic methods leading to α-alkylidene γ-lactams through Wittig or Horner-Wadsworth-Emmons olefination reactions and radical-and transition-metal-mediated cyclizations, respectively. In turn, Millemaggi and Taylor devoted their 2010 review [4] to the biological activities and syntheses of natural and synthetic 3-alkenyloxindoles, which are a specific group of α-alkylidene γ-lactams.…”
Section: Introductionmentioning
confidence: 99%